This is a working overview of hGH fragment, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-07-06 and is reviewed periodically as new material appears.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Major agencies have not authorized it for therapeutic use. |
| Anti-doping status | Prohibited in sport | Listed among peptide hormones and related substances. |
| Primary research area | Metabolic and body-composition effects | Studies often examine fat mass or lipid markers. |
| Human evidence | Limited and mixed | Public data do not establish clinical efficacy. |
| Analytical detection | LC-MS and immunoassays | Methods vary in sensitivity and validation. |
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
The 200 year old doctrine has had different effects depending on the era in which it was employed but its central theme has stayed the same: to maintain US hegemony in trade routes, trade deals, security, and access in the Western Hemisphere.
=== Philippines === The Armed Forces of the Philippines formerly had a combat ration similar to American MREs. Typically, they included a small can of sardines or tuna, instant noodles, crackers, instant coffee, a small packet of peanuts, ginger tea, and a biscuit or cookie. Chocolate manufactured for hot conditions are sometimes issued. Canned rice is also issued. In 2016, "Ready-to-Eat" rations were announced to replace older rations. They are packed in green plastic retort pouches and considered fit to eat for Muslim service members (halal). For example, Menu #2 has four packs of cooked rice, one tuna rice with sisig, one pack of chicken sausage with sauce, one pack of chicken lechon paksiw, one pack of powdered milk, one pack of 3-in-1 coffee, one pack of plain crackers, a spork, and wet tissues.
== See also == Aerogel – Synthetic ultralight solid material Biomineralization – Process by which living organisms produce minerals Fuller's earth – Any clay material that can decolorise oil or other liquids Perlite – Amorphous volcanic glass Rock flour – Glacier-generated sediment Siliceous ooze – Biogenic pelagic sediment located on the deep ocean floor Zeolite – Microporous, aluminosilicate mineral group
A follow-up analysis, and a letter to the editor by Gregory Francis from the Department of Psychological Sciences, Purdue University, demonstrated that the problem in the paper could be a simple reporting error in which t-statistics were reported as F-statistics by mistake. Francis also showed that this error does not negate the findings in the original article. In November 2022, the Israeli TV investigative show Hamakor (Channel 13), aired an episode questioning a number of Ariely's studies that were not reproducible or whose reliability was dubious in terms of the way they were carried out, the data collected, or whether the studies were carried out at all. For example, Ariely claimed that data for his "Ten Commandments" study were collected in 2004–2005 at UCLA with the assistance of Aimee Drolet Rossi. However, despite being thanked in the 2004 paper for collecting the data almost 20 years later, Rossi denies having run the study, and UCLA has issued a statement that the study did not take place there. Ariely told The New Yorker that the surveys were collected at UCLA but processed by an assistant at MIT, a mixup that he credited for the confusion surrounding Rossi and UCLA's role in the study. An analysis conducted by the American Marketing Association on the study in question found that the study's results were largely replicable using the data provided by the authors, although conditions had been dropped from the first two experiments in the study.
== Pathophysiology == Normal glucose homeostasis is controlled by three interrelated processes. These processes include gluconeogenesis (glucose production that occurs in the liver), uptake and utilization of glucose by the peripheral tissues of the body, and insulin secretion by the pancreatic beta islet cells. The presence of glucose in the bloodstream triggers the production and release of insulin from the pancreas' beta islet cells. The main function of insulin is to increase the rate of transport of glucose from the bloodstream into certain cells of the body, such as striated muscles, fibroblasts, and fat cells. It also is necessary for transport of amino acids, glycogen formation in the liver and skeletal muscles, triglyceride formation from glucose, nucleic acid synthesis, and protein synthesis. In individuals with prediabetes, a failure of pancreatic hormone release, failure of targeted tissues to respond to the insulin present or both leads to blood glucose rises to abnormally high levels.
Sources: en.wikipedia.org
It has been shown that the tetradentate binding configuration of copper(I) in mbOB3b necessitates the ligation of a water molecule to the copper ion as a ligand. This has been used to argue that water is the source of electrons for reducing the bound metal ion. Others have suggested that the disulfide bridge in methanobactin's structure is the source of the electron, though XPS has shown that this bond is still intact in copper-bound methanobactin. The source of this reducing electron remains elusive at the moment.
== History == Salad and Go was founded in 2013 in Gilbert, Arizona by Tony and Roushan Christofellis. The co-founders asked Chef Daniel Patino to help them develop the concept. Chef Patino remains an executive chef for the brand. In March 2022, industry veteran Charlie Morrison joined Salad and Go as Chief Executive Officer (CEO). Since Morrison joined, the brand has expanded rapidly into major markets including the Dallas–Fort Worth metroplex, Houston, Las Vegas and Oklahoma City while continuing to open locations in its home state of Arizona. Salad and Go was on track to have a total of 135 stores open by the end of 2023. In January 2024, CEO Charlie Morrison said it was on pace to continue to open up a restaurant a week and described his plans for thousands of locations. On September 19, 2025, Salad and Go closed all stores in Houston, San Antonio, and Austin, along with some in North Texas, with a total of 41 closures. New CEO Mike Tattersfield stated the move was to focus on more disciplined growth. In January 2026, Salad and Go announced it would be closing all its remaining Texas and Oklahoma locations and focusing on strengthening its operations in Arizona and Nevada. The company also announced it would be relocating its headquarters from Coppell, Texas, back to the Phoenix area. On August 4, 2026, Salad and Go filed for Chapter 11 bankruptcy protection and announced the permanent closure of all remaining locations effective the next day, August 5. As a result, plans for the new headquarters were scrapped.
=== Fertilizers === Metal chelate compounds are common components of fertilizers to provide micronutrients. These micronutrients (manganese, iron, zinc, copper) are required for the health of the plants. Most fertilizers contain phosphate salts that, in the absence of chelating agents, typically convert these metal ions into insoluble solids that are of no nutritional value to the plants. EDTA is the typical chelating agent that keeps these metal ions in a soluble form.
== Signs and symptoms == Symptoms of cold agglutinin disease (CAD) are often triggered or made worse by cold temperatures or a viral infection. Therefore, symptoms generally are worse during winter months. Symptoms may arise suddenly leading to abrupt onset of severe anemia and hemoglobinuria or develop more gradually and insidiously in the background without patient's consciousness and precaution. Most people with CAD have symptoms of hemolytic anemia (destruction of red blood cells, causing low levels of red blood cells). However, the number of symptoms and severity of symptoms may depend on how severe the anemia is. Signs and symptoms of hemolytic anemia may include:
BCN, also known as bicyclo[6.1.0]non-4-yne, is a copper-free click chemistry probe that enables highly efficient and completely orthogonal bioconjugation to complex macromolecules including peptides, nucleic acids and proteins, including monoclonal antibodies. The most recent and powerful application of this technology has been in the field of antibody-drug conjugates which results in targeted cancer therapeutics that have an improved therapeutic index, meaning they are more effective and better tolerated. BCN is well-suited for aqueous bioconjugations due to its high reactivity with its azide counterpart and its high hydrophilicity, relative to other metal-free click chemistry probes.
Sources: en.wikipedia.org
==== Desert lung disease ==== A non-occupational form of silicosis, desert lung disease, is caused by long-term exposure to sand dust in desert areas, with cases reported from the Sahara, Libyan desert and the Negev. The disease is caused by deposition of sand dust in the lungs. Desert lung disease may be related to Al Eskan disease, a lung disorder thought to be caused by exposure to sand dust containing organic antigens, first diagnosed after the Gulf War. The relative importance of the silica particles and the microorganisms that they carry in health effects remains unclear.
The liver is found in all vertebrates and is typically the largest internal organ. The internal structure of the liver is broadly similar in all vertebrates, though its form varies considerably in different species, and is largely determined by the shape and arrangement of the surrounding organs. Nonetheless, in most species, it is divided into right and left lobes; exceptions to this general rule include snakes, where the shape of the body necessitates a simple cigar-like form. In neonatal marsupials, it is responsible for the production of blood cells. An organ sometimes referred to as a liver is found associated with the digestive tract of the primitive chordate amphioxus. Although it performs many functions of a liver, it is not considered a "true" liver but rather a homolog of the vertebrate liver. The amphioxus hepatic caecum produces the liver-specific proteins vitellogenin, antithrombin, plasminogen, alanine aminotransferase, and insulin/insulin-like growth factor.
Raoult's law A law of thermodynamics which states that the partial pressure of each gaseous component of an ideal mixture of liquids is equal to the vapor pressure of the pure component multiplied by its molar fraction in the mixture.
Hence, alternative chemical models of proteins were considered, such as the diketopiperazine hypothesis of Emil Abderhalden. However, no alternative model had yet explained why proteins yield only amino acids and peptides upon hydrolysis and proteolysis. As clarified by Linderstrøm-Lang, these proteolysis data showed that denatured proteins were polypeptides, but no data had yet been obtained about the structure of folded proteins; thus, denaturation could involve a chemical change that converted folded proteins into polypeptides. The process of protein denaturation (as distinguished from coagulation) had been discovered in 1910 by Harriette Chick and Charles Martin, but its nature was still mysterious. Tim Anson and Alfred Mirsky had shown that denaturation was a reversible, two-state process that results in many chemical groups becoming available for chemical reactions, including cleavage by enzymes. In 1929, Hsien Wu hypothesized correctly that denaturation corresponded to protein unfolding, a purely conformational change that resulted in the exposure of amino-acid side chains to the solvent. Wu's hypothesis was also advanced independently in 1936 by Mirsky and Linus Pauling. Nevertheless, protein scientists could not exclude the possibility that denaturation corresponded to a chemical change in the protein structure, a hypothesis that was considered a (distant) possibility until the 1950s. X-ray crystallography had just begun as a discipline in 1911, and had advanced relatively rapidly from simple salt crystals to crystals of complex molecules such as cholesterol.
Sources: en.wikipedia.org
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.
It is classified among peptide hormones and related substances that are prohibited in sport. The ban reflects anti-doping rules rather than a judgment that the peptide is effective for performance enhancement.
Human studies are limited and have not produced consistent evidence of meaningful clinical benefit. Some early trials examined metabolic endpoints, but larger confirmatory trials are generally lacking.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.